Antifungal stewardship in a tertiary-care institution: a bedside intervention

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
M ValerioCOMIC Study Group Collaborative Group on Mycosis

Abstract

Antifungal stewardship (AFS) programmes are needed in tertiary-care hospitals. Our aim is to describe a bedside non-restrictive AFS programme, and to evaluate its economic impact. During the first year of the AFS a bundle of non-interventional measures were implemented. During the second year an infectious diseases specialist visited 453 patients receiving candins, liposomal amphotericin B, voriconazole or posaconazole. Monthly costs were studied with an interrupted time series (ITS) analysis. The main prescribing departments were haematology (35%), medical departments (23%), and intensive care units (20%). Reasons to start antifungal therapy were: targeted therapy (36%), prophylaxis (32%), empirical therapy (20%) and pre-emptive therapy (12%). At the initial visit, diagnostic advice was provided in 40% of cases. The most common therapeutic recommendations were to de-escalate the antifungal drug (17%) or to suspend it (7%). Annual total antifungal expenditure was reduced from US$3.8 million to US$2.9 million over the first 2 years, generating net savings of US$407,663 and US$824,458 per year after considering the cost of additional staff required. The ITS analyses showed a significant economic impact after the first 12 months o...Continue Reading

References

Mar 27, 2004·The Journal of Antimicrobial Chemotherapy·Paul P CookRonald E Polk
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy H DellitUNKNOWN Society for Healthcare Epidemiology of America
Nov 6, 2007·Médecine et maladies infectieuses·P PaveseP François
Jan 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshUNKNOWN Infectious Diseases Society of America
Dec 2, 2008·Médecine et maladies infectieuses·S RaymondJ Leroy
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
May 26, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Anucha ApisarnthanarakUNKNOWN Thammasat University Antimicrobial Stewardship Team
Jul 28, 2010·Bone Marrow Transplantation·J MaertensUNKNOWN Third European Conference on Infections in Leukemia
Nov 30, 2011·Current Opinion in Infectious Diseases·Michelle R Ananda-RajahKarin T Thursky
Feb 3, 2012·Critical Care Medicine·Elie AzoulayJean-François Timsit
Mar 16, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Harold C StandifordGraeme N Forrest
May 4, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F López-MedranoJ M Aguado
Jul 11, 2012·The Journal of Antimicrobial Chemotherapy·Yasmine NivoixRaoul Herbrecht
Oct 27, 2012·International Journal of Clinical Pharmacy·Anthony J GuarascioArif R Sarwari
Feb 19, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M BassettiE Righi
Jul 11, 2013·The Journal of Antimicrobial Chemotherapy·Rosemary A Barnes
Mar 25, 2014·The Journal of Antimicrobial Chemotherapy·Maricela ValerioUNKNOWN COMIC Study Group (Collaborative Group on Mycoses)
Jul 30, 2014·Enfermedades infecciosas y microbiología clínica·Maricela ValerioUNKNOWN COMIC study group (Collaborative group on Mycosis)

❮ Previous
Next ❯

Citations

Jan 8, 2016·Infectious Disease Clinics of North America·Philipp Koehler, Oliver A Cornely
Apr 15, 2016·Expert Review of Anti-infective Therapy·Jan-Willem H DikAlexander W Friedrich
Oct 8, 2016·International Journal of Clinical Pharmacy·Maria Clara Padovani de SouzaAdriano Max Moreira Reis
Nov 24, 2016·The Journal of Antimicrobial Chemotherapy·Patricia MuñozUNKNOWN COMIC (Collaboration Group on Mycosis) study group
Jul 18, 2018·Antimicrobial Agents and Chemotherapy·Lisa NwankwoDarius Armstrong-James
Oct 10, 2018·Current Opinion in Infectious Diseases·Karen F UrbancicMonica A Slavin
Jun 25, 2019·Medical Mycology·Ana Fernández-CruzPatricia Muñoz
Aug 14, 2019·Pediatric Blood & Cancer·Begoña Santiago-GarcíaUNKNOWN POPA Study Group
Jan 6, 2018·The Journal of Antimicrobial Chemotherapy·Frederic LamothThierry Calandra
Jul 15, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lourdes EguigurenHayden T Schwenk
Oct 4, 2020·International Journal of Clinical Pharmacy·Zainab ReslanRochelle Gellatly
Nov 21, 2017·The Journal of Antimicrobial Chemotherapy·A L BienvenuG Leboucher
Jan 27, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Caroline AgnelliUNKNOWN COMIC Study Group (Collaborative Group on Mycosis)
Feb 7, 2020·Infectious Diseases and Therapy·Antonio VenaEmilio Bouza
Sep 27, 2018·The Journal of Antimicrobial Chemotherapy·R Rautemaa-RichardsonE G Muldoon
Aug 7, 2020·The Journal of Infectious Diseases·Melissa D JohnsonDimitrios P Kontoyiannis

Jan 5, 2021·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Apr 7, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Dawood YusefMamoon A Aldeyab
May 6, 2021·Journal of Fungi·William Alegria, Payal K Patel
Jun 22, 2021·Antimicrobial Agents and Chemotherapy·Emre KaraOmrum Uzun
Oct 1, 2021·Japanese Journal of Infectious Diseases·Yan WangSamantha A Hollingworth
Dec 23, 2021·Internal Medicine Journal·Anna KhaninaUNKNOWN Australasian Antifungal Guidelines Steering Committee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
F López-MedranoJ M Aguado
The New England Journal of Medicine
Anucha ApisarnthanarakPablo Tebas
The New England Journal of Medicine
Andrew J UllmannOliver A Cornely
© 2022 Meta ULC. All rights reserved